Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
, , e
18 giu 2022
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Short Communication
Pubblicato online: 18 giu 2022
Pagine: 84 - 86
Ricevuto: 25 apr 2022
Accettato: 10 mag 2022
DOI: https://doi.org/10.2478/afpuc-2022-0006
Parole chiave
© 2022 Jan Juřica et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Juřica, Jan
Faculty of Medicine, Department of Pharmacology, Masaryk UniversityBrno, Czech Republic
Masaryk Memorial Cancer InstituteBrno, Czech Republic
Faculty of Pharmacy, Department of Pharmacology and Toxicology, Masaryk UniversityBrno, Czech Republic
Goněc, Roman
Masaryk Memorial Cancer InstituteBrno, Czech Republic
Bártová, Adela
Faculty of Medicine, Department of Pharmacology, Masaryk UniversityBrno, Czech Republic
Gregorová, Jana
Faculty of Medicine, Department of Biochemistry, Masaryk UniversityBrno, Czech Republic